<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2026-11-05</publicationDate>
    
        <volume>19</volume>
        <issue>4</issue>

 
    <startPage></startPage>
    <endPage></endPage>

	    <publisherRecordId>74041</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">AI-Driven Reverse Pharmacognosy: Target-Guided Bioprospecting with Integrated Conservation Prioritization</title>

    <authors>
	 


      <author>
       <name>Atul Rupchand Bendale</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Vasimkhan Taslimkhan Pathan</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Vaishali Dattattray Naphade</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	 


      <author>
       <name>Tushar Dilip Fegade</name>

		
	<affiliationId>4</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of pharmaceutical chemistry, Mahavir Institute of pharmacy, Nashik, India</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of pharmaceutics, Mahavir Institute of pharmacy, Nashik, India</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of pharmacology, Sandip University, School of pharmaceutical sciences, Nashik, India</affiliationName>
    
		
		<affiliationName affiliationId="4">Department of pharmaceutics, Shellino Education Society's Arunamai College of Pharmacy Mamurabad, Jalgaon, India</affiliationName>
    
		
		
	  </affiliationsList>






    <abstract language="eng">This review provides an overview of the new paradigm of reverse pharmacognosy, which has been developed using AI, and provides a comprehensive analysis of this paradigm. Unlike the traditional plant collection, bioactivity screening and target identification process, this strategy starts with a predetermined therapeutic target (a molecule) and uses artificial intelligence to foretell which plant species is most likely to have a bioactive ligand that could activate the target. The review critically evaluates the data that needs to be utilized to feed into these predictive models, including chemical, genomic, metabolomic and conservation databases. It covers in detail key computational approaches that take data to testable hypotheses such as virtual screening, network-based activity propagation and explainable AI (XAI). One main idea is the need to incorporate the IUCN Red List status and cultivation potential of candidates directly into the candidate scoring algorithms, thus promoting a conservation-driven approach to bioprospecting. The review addresses not only the retrospective but also the prospective case studies confirming the paradigm, but also outlines some important technical hurdles and ethical issues such as the biases associated with data and the concerns of digital biopiracy and suggests future directions that combine the application of AI and genome mining with predictive metabolomics in global collaborations. The main conclusion is that AI in reverse pharmacognosy can be a rational approach to speed up the discovery of natural products and contribute to the conservation of biodiversity, through transparent sustainability parameters.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol19no4/ai-driven-reverse-pharmacognosy-target-guided-bioprospecting-with-integrated-conservation-prioritization/</fullTextUrl>

<keywords language="eng">

      
        <keyword>AI-driven reverse pharmacognosy</keyword>
      

      
        <keyword> Biosynthetic gene clusters (BGCs)</keyword>
      

      
        <keyword> Conservation prioritization</keyword>
      

      
        <keyword> Digital biopiracy</keyword>
      

      
        <keyword> explainable AI (XAI)</keyword>
      

      
        <keyword> In silico screening</keyword>
      

      
        <keyword> Natural product databases</keyword>
      

      
        <keyword> Phylogenetic prediction</keyword>
      

      
        <keyword> Sustainable bioprospecting</keyword>
      

      
        <keyword> Target-based drug discovery</keyword>
      
</keywords>
  </record>
</records>